60 Degrees Pharmaceuticals, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $207 | $162 | $303 | $437 |
Gross Profit | 56 | 76 | 182 | -100 |
EBITDA | -2,233 | -2,069 | -1,414 | -2,292 |
EBIT | -2,264 | -2,094 | -1,437 | -2,315 |
Net Income | -2,264 | -2,090 | -1,441 | -2,317 |
Net Change In Cash | 207 | 162 | 303 | 437 |
Free Cash Flow | -2,231 | -2,771 | -1,827 | -2,119 |
Cash | 1,022 | 3,337 | 1,510 | 4,115 |
Basic Shares | 2,653 | 1,725 | 1,163 | 918 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $1,005 | $607 | $253 | $223 |
Gross Profit | 223 | 222 | -220 | -209 |
EBITDA | -7,277 | -7,883 | -1,426 | -2,109 |
EBIT | -7,360 | -7,947 | -1,526 | -2,187 |
Net Income | -7,368 | -7,947 | -3,765 | -6,181 |
Net Change In Cash | 1,005 | 607 | 253 | 223 |
Free Cash Flow | -7,067 | -5,829 | -4,658 | -1,070 |
Cash | 1,510 | 1,659 | 2,142 | 264 |
Basic Shares | 670 | 113 | 24 | 24 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.90 |
2026-03-31 | -$1.21 |
2025-12-31 | -$8.17 |
2025-09-30 | -$2.53 |